Gilead’s new biannual HIV prevention shot receives FDA clearance
The FDA Approves AI Tools for Breast Cancer Risk Assessment The U.S. Food and Drug Administration (FDA) has given the green light to two new shots, happening only once a year, aimed at preventing HIV, as announced by Gilead Sciences on Wednesday. The injectable medication, known as Lenacapavir and marketed under the name Yeztugo, significantly […]